Abstract |
In order to evaluate the clinical significances of the
serum vitamin B12, folate and ferritin levels in
patients with malignant tumors, the levels were
measured in 10 normal control subjects, 70 patients
with malignant tumors, 7 patients with liver cirrhosis
and 25 patients with other benign diseases. The results
are as follows: 1) In normal control subjects, mean
serum values for vitamin B12, folate and ferritin level
were 588.80¡¾ 131.58 pg/ml, 5.59¡¾1.52 ng/ml and
89.22¡¾42.78 ng/ml retrospectively. 2) There was no
significant difference in serum levels between patients
with benign diseases and normal control subjects. 3)
The serum vitamin B12 and ferritin levels in patients
with liver cirrhosis were significantly higher than in
normal control, and the serum folate levels in these
patients were lower than in normal control subjects. 4)
The serum vitamin B12 and ferritin levels in patients
with malignant tumors were significantly higher than in
normal control subjects, and the serum folate levels in
these patients were significantly lower than in normal
control subjects. The above results suggest that the
serum vitamin B12 and ferritin may be useful as tumor
markers in patients with malignant tumors. |